SCHEMBL13280355

SCHEMBL13280355

COc1cccc(OC)c1C=Cc1ccc(O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 4/20 0.64
▸ CYP1B1 Q16678 4/20 0.64
▸ CYP1A2 P05177 3/20 0.64
▸ MAPT P10636 4/20 0.57
▸ APP P05067 3/20 0.57
▸ TTR P02766 3/20 0.53
▸ ALOX5 P09917 3/20 0.53
▸ PTGS2 P35354 3/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ ABL1 P00519 2/20 0.53
▸ ABCB1 P08183 2/20 0.53
▸ GAA P10253 2/20 0.53
▸ BCR P11274 2/20 0.53
▸ NQO2 P16083 2/20 0.53
▸ PTGS1 P23219 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ GFER P55789 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5492159 0.83 CYP1A1 (0.66) CYP1A1CYP1B1CYP1A2APPTTR
SCHEMBL5492154 0.83 CYP1A1 (0.66) CYP1A1CYP1B1CYP1A2APPTTR
SCHEMBL5497383 0.82 NFE2L2 (0.66) CYP1A1CYP1B1CYP1A2MMP1MMP2
SCHEMBL5497385 0.82 NFE2L2 (0.66) CYP1A1CYP1B1CYP1A2MMP1MMP2
SCHEMBL4700886 0.81 CYP1A1 (0.64) CYP1A1CYP1B1CYP1A2ABCG2ALDH1A1
SCHEMBL3211619 0.81 BACE1 (0.74) CYP1A2MAPTAPPALOX5PTGS2
SCHEMBL3211604 0.81 BACE1 (0.74) CYP1A2MAPTAPPALOX5PTGS2
SCHEMBL19327368 0.80 NFE2L2 (0.73) CYP1A1CYP1B1CYP1A2MAPTAPP
SCHEMBL633823 0.80 NFE2L2 (0.73) CYP1A1CYP1B1CYP1A2MAPTAPP
SCHEMBL3474871 0.80 NFE2L2 (0.74) CYP1A1CYP1B1CYP1A2MAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9610258-B2 Methods of stabilizing the extracellular matrix and compositions therefor MD MATRIX HEALTH LLC (US) 2017-04-04 — — US disclosed
US-20160243057-A1 METHODS OF STABILIZING THE EXTRACELLULAR MATRIX AND COMPOSITIONS THEREFOR MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC (US) 2016-08-25 — — US disclosed
US-20140193480-A1 TOPICAL ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC. (US) 2014-07-10 — — US disclosed
WO-2012142511-A2 ORTHOMOLECULAR COMPOSITIONS AND THEIR USE IN STABILIZING THE EXTRACELLULAR MATRIX MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC (US) 2012-10-18 — — WO disclosed
Send feedback